Skip to main content

Advertisement

SpringerLink
Log in

Quality by design approach for development and optimization of Quetiapine Fumarate effervescent floating matrix tablets for improved oral bioavailability

  • Original Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

The aim of the investigation was to develop and optimize the effervescent floating matrix tablets of Quetiapine Fumarate (QF) by using 23 factorial design. Amount of hydroxyl propyl methyl cellulose K4M (HPMC K4M (A1)), amount of hydroxyl propyl methyl cellulose K15M (HPMC K15M (A2)) and amount of sodium bicarbonate (A3) (as gas-generating agent) were considered as independent variables and floating lag time (FLT, B1) (sec), percent drug release in 2 h (B2, Q2) and 6 h (B3, Q6) as dependent variables, respectively. Floating tablets of QF were prepared by effervescent technique using direct compression method. Drug-excipient compatibility studies were conducted by using DSC and FTIR techniques. The floating tablets were evaluated for physical characteristics, drug content, swelling index, in vitro buoyancy and in vitro release studies. Optimized formulation contains 25 mg of A1, 12.5 mg of A2 and 25 mg of A3 which resulted in 32 s of B1, 32.89 ± 3.1 % of B2, and 73.61 ± 1.8 % of B3, respectively. DSC and FTIR studies revealed that no interaction between the drug and excipients in the developed formulation. The drug release followed Higuchi model and the Fickian transport. Physico-chemical stability studies revealed that the optimized formulation was stable for 90 days. Based on the physical evaluation and in vitro drug release characteristics, it was concluded that QF was suitable for incorporation into a floating drug delivery system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Araujo PW, Brereton RG (1996) Experimental design 1, screening. Trends Anal Chem 15:26–31

    CAS  Google Scholar 

  • Arora S, Ali J, Ahuja A, Khar RK, Baboota S (2005) Floating drug delivery systems: a review. AAPS Pharm Sci Tech 6(3):372–390

    Article  Google Scholar 

  • Basak SC, Rahman J, Ramalingam M (2007) Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride. Pharmazie 60(2):145–148

    Google Scholar 

  • Baumgartner S, Kristi J, Vrecer F, Vodopivec P, Zorko B (2000) Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 195:125–135

    Article  CAS  PubMed  Google Scholar 

  • Box GE, Hunter WG, Hunter JS (2005) Statistics for experimenters: design, innovation, and discovery, 2nd edn. Wiley, New York. ISBN ISBN 978-0-471-71813-0

  • Bui K, Earley W, Nyberg S (2013) Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications. Curr Med Res Opin 29(7):813–825

    Article  CAS  PubMed  Google Scholar 

  • Chavanpatil M, Jain P, Chandhari S, Shear R, Vavia P (2005) Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm 304:178–184

    Article  CAS  PubMed  Google Scholar 

  • Chawla G, Bansal A (2003) A means to address regional variability in intestinal drug absorption. Pharm Technol 27:50–68

    Google Scholar 

  • Davis SS, Stockwell AF, Taylor MJ (1986) The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm Res 3:208–213

    Article  CAS  PubMed  Google Scholar 

  • Deshpande AA, Rhodes CT, Shah NH, Malick AW (1996) Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 22:531–539

    Article  CAS  Google Scholar 

  • Deshpande AA, Shah NH, Rhodes CT, Malick W (1997) Development of a novel controlled-release system for gastric retention. Pharm Res 14:815–819

    Article  CAS  PubMed  Google Scholar 

  • Doodipala N, Palem RC, Reddy S, Rao Y (2011) Pharmaceutical development and clinical pharmacokinetic evaluation of gastroretentive floating matrix tablets of levofloxacin. Int J Pharm Sci Nanotech 4:1463–1469

    Google Scholar 

  • Fisher R (1926) The arrangement of field experiments (PDF). J Minist Agric Great Br 33:503–513

    Google Scholar 

  • Garg R, Gupta GD (2009) Preparation and evaluation of gastro retentive floating tablets of acyclovir. Curr Drug Deliv 6(5):437–443

    Article  CAS  PubMed  Google Scholar 

  • Hadi MA, Babu VL, Pal N (2012) Formulation and evaluation of sustained release matrix tablets of glimepiride based on combination of hydrophilic and hydrophobic polymers. J Appl Pharm Sci 2:101–107

    Google Scholar 

  • Higuchi T (1963) Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–1148

    Article  CAS  PubMed  Google Scholar 

  • Iannuccelli V, Coppi G, Bernabei MT, Cameroni R (1998) Air compartment multiple unit system for prolonged gastric residence. Part I. Formulation study. Intl J Pharm 174:47–54

    Article  CAS  Google Scholar 

  • Korsmeyer R, Gurny R, Peppas N (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35

    Article  CAS  Google Scholar 

  • Menon A, Ritschel WA, Sakr A (1994) Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci 83:239–245

    Article  CAS  PubMed  Google Scholar 

  • Narendar Reddy D, Chinna Reddy P, Sunil R, Madhusudan Rao Y (2012) Development of floating matrix tablets of Ofloxacin and Ornidazole in combined dosage form: in vitro and in vivo evaluation in healthy human volunteers. Int J Drug Del 4(4):462–469

    CAS  Google Scholar 

  • Peppas NA (1985) Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–111

    CAS  PubMed  Google Scholar 

  • Rosa M, Zia H, Rhodes T (1994) Dosing and in vitro testing of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 105:65–70

    Article  Google Scholar 

  • Santus G, Lazzarini G, Bottoni G et al (1997) An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm 44:39–52

    Article  CAS  Google Scholar 

  • Sudhalakshmi P, Vardhan SVM, Ramachandran D, Rambabu C (2009) UV spectrophotometric determination of quetiapine and zonisamide. Asian J Chem 21(1):811–813

    Google Scholar 

  • Wagner JG (1969) Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 58:1253–1257

    Article  CAS  PubMed  Google Scholar 

  • Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM (1998) Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Rel 55:3–12

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge M/s Hetero Drugs Ltd., Hyderabad, India for providing drug. One of the authors (Someshwar. K) thanks AICTE, New Delhi for providing fellowship to carry out this research work.

Declaration of interest

Authors declare that no conflict of interest is there in this study.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Centre for Biopharmaceutics and Pharmacokinetics, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, TS, 506009, India

    D. Narendar, N. Arjun, K. Someshwar & Y. Madhusudan Rao

Authors
  1. D. Narendar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Arjun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Someshwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Madhusudan Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narendar, D., Arjun, N., Someshwar, K. et al. Quality by design approach for development and optimization of Quetiapine Fumarate effervescent floating matrix tablets for improved oral bioavailability. Journal of Pharmaceutical Investigation 46, 253–263 (2016). https://doi.org/10.1007/s40005-016-0232-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-016-0232-5

Keywords

Search

Navigation